Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

3.12
Delayed Data
As of Sep 28
 +0.01 / +0.32%
Today’s Change
2.81
Today|||52-Week Range
5.35
-23.90%
Year-to-Date

Today’s Trading

Previous close3.11
Today’s open3.20
Day’s range3.11 - 3.24
Volume23,288
Average volume (3 months)56,968
Market cap$28.6M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+47.37%
Earnings growth (this year)+14.50%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.67%
P/E ratioNM
Price/Sales1.80
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
BIODBiodel Inc-0.01-1.14%
CERUCerulean Pharma Inc0.000.00%
IMNPImmune Pharmaceutica...-0.01-3.47%
KTOVKitov Pharmaceutical...-0.08-2.21%
Data as of 4:00pm ET, 09/28/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$21.0M
Annual profit (last year)-$9.2M
Net profit margin-44.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs